Ionis Pharmaceuticals IONS
NASDAQ IONS
$43.54 -0.46 (-1.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ionis Pharmaceuticals (IONS) Income from Discontinued Operations (2009)

Updated

Ionis Pharmaceuticals (IONS) recorded Income from Discontinued Operations of -$1.5 million in Q4 2009.

Analysis

Ionis Pharmaceuticals (IONS) Income from Discontinued Operations (2009) Analysis & Trends

For FY2009, Ionis Pharmaceuticals reported Income from Discontinued Operations of $185.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Ionis Pharmaceuticals 7.21 Bn -1.68 Bn 265.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 -1.50 Mn
Sep 30, 2009 34,000.00
Jun 30, 2009 94,000.00
API Access

Ionis Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=IONS&period=max&api_key=YOUR_API_KEY